---
title: Certara vs Frontage Laboratories
slug_a: certara
slug_b: frontagelab
site: cro
review_signal_gate: closed
canonical_path: /compare/certara/frontagelab
generated_by: BioBM Editorial AI
---

# Certara vs Frontage Laboratories

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Certara (certara) is listed for cro. Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.

Services: 37. Modalities: 20. Indications: 25. Locations: 8. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (37).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Frontage Laboratories (frontagelab) is listed for cro. Global pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.

Services: 37. Modalities: 5. Indications: 1. Locations: 2. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (37).

Review summary: Review summary withheld until site-level review gate opens.